NewSpring Capital, based in Radnor, Pennsylvania, has spent more than 25 years partnering with founders and management teams in the lower-middle market. Founded in 1999, it operates through five strategies, Growth, Healthcare, Mezzanine, Holdings and Franchise, and reports more than $3.5 billion in assets under management across more than 250 portfolio companies.

Investment thesis

NewSpring backs scalable, capital-efficient businesses in the lower-middle market, primarily in the US Mid-Atlantic and beyond, and it partners with management teams rather than replacing them. Its growth strategy targets business services, enabling technology and information technology; its healthcare strategy covers healthcare services, specialty pharmaceuticals and medical devices; and its mezzanine strategy provides flexible debt and equity for expansion and buyouts in business services, healthcare, information technology and specialty manufacturing.

Cheque size and fund size

Across the firm, assets under management exceed $3.5 billion, with more than $3.4 billion in realizations since inception. Its growth funds illustrate the cheque range: NewSpring Growth Capital III closed at its $250 million hard cap in 2013 and invested $5 million to $25 million in growth-stage businesses with $5 million to $50 million of revenue. The mezzanine strategy alone manages $1.3 billion, has invested $1.5 billion across more than 120 investments, and operates an SBIC fund. The size of the firm's newest funds is not publicly disclosed.

Notable portfolio companies

NewSpring's growth portfolio has included data company eXelate, which received an $8.2 million investment, and power-management company Raritan. Its Holdings buy-and-build strategy owns platforms including USPack, a national same-day and next-day delivery logistics company, Magna5, a cloud communications provider, Vertical Management Systems and Wealthcare Capital Management. Co-founder and managing general partner Michael DiPiano leads the firm, which counts more than 70 professionals, many with operating experience.

Programs, credits and perks

NewSpring runs no public accelerator or startup credits programme. Its support model is built around in-house operating partners who work hands-on with portfolio companies, plus a network of operators, board members and advisors built over 25 years. The mezzanine strategy's SBIC fund status is a structural advantage for eligible lower-middle-market companies rather than a founder-facing perk.

How to apply for funding

NewSpring Capital has no open application portal. Founders reach the team through a warm introduction via a portfolio executive, a Mid-Atlantic co-investor or an advisor in its network, or through the contact routes on newspringcapital.com. Because the firm runs five distinct strategies, the most important step is targeting the right one: growth equity for a scaling technology or services business, healthcare for a healthcare company, or mezzanine for a profitable business seeking flexible expansion or buyout capital.

Why it matters for founders

NewSpring Capital is worth approaching if you run a capital-efficient lower-middle-market business and want a partner that can flex between growth equity, healthcare capital and mezzanine debt as your needs change. Its twenty-five-year record and multi-strategy platform mean one relationship can support several stages of growth, provided your business already has real revenue behind it.